Our latest investorview this week is with Christoph Ruedig, Partner at Albi...

We have published our annual investor perception survey, confirming or disp...

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Investment for Advanced Therapies will be the C-Level meeting place for hea...

We’re delighted to announce further additions to the lineup of presenters a...

Family Offices are, by design, a much more private group than other other i...

Leaving the EU would have enormous implications for biotech and life scienc...

In this article, Professor Lord Darzi of Denham, director of the Institute ...

If the UK votes to exit the European Union (Brexit) following the referendu...

With the UK's referendum on whether Britain should leave the European Union...

At the Inv€$table CEO Pitch Breakfast hosted by K&L Gates on Tuesday 24th M...

Leaders from across scientific disciplines tell MPs leaving EU would relega...